STOCK TITAN
  1. Home
  2. Financials
  3. TTNP
  4. EPS (Diluted)

TITAN PHARMACEUTICAL INC (TTNP) EPS by Year

TTNP

TITAN PHARMACEUTICAL INC lost $5.23 per diluted share in fiscal year 2024. This represents an increase of 29.4% from the prior fiscal year. Over the trailing 12 months, Q3 FY2024 through Q2 FY2025, the same line adds up to a loss of $2.95 per diluted share. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters TITAN PHARMACEUTICAL INC has filed alongside them.

FY2024 annual
EPS (Diluted) -$5.23
YoY +29.4%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2025, ended Jun 30, 2025 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

TTNP EPS (Diluted) by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricTTMFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-KFY1010-K
EPS (Diluted)-$2.95-$5.23+29.4%-$7.41+51.2%-$15.19-$0.90+54.1%-$1.96-$0.72-$1.66-$4.22-451.7%$1.20-$0.56-$0.20$0.53-$0.23+17.9%-$0.28N/A

TTM is the trailing twelve months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.

TTNP EPS (Diluted) by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2510-QQ1'2510-QQ4'2410-QQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-QQ2'2310-QQ1'2310-QQ4'2210-KQ3'2210-Q
EPS (Diluted)-$0.65+71.6%-$0.62+50.0%-$0.85+88.1%-$0.83-$2.29-$1.24-$7.14-$0.45-$2.11-$2.23-$14.60-$0.18+5.3%

What diluted earnings per share means

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports.

More TITAN PHARMACEUTICAL INC financials

Frequently Asked Questions

What was TITAN PHARMACEUTICAL INC's diluted earnings per share in fiscal year 2024?

TITAN PHARMACEUTICAL INC lost $5.23 per diluted share in fiscal year 2024.

How fast is TITAN PHARMACEUTICAL INC's diluted earnings per share growing?

TITAN PHARMACEUTICAL INC (TTNP) diluted earnings per share rose by 29.4% year over year, from -$7.41 to -$5.23 in fiscal year 2024.

What is TITAN PHARMACEUTICAL INC's diluted earnings per share over the last twelve months?

TITAN PHARMACEUTICAL INC (TTNP) reported a loss of $2.95 per diluted share over the trailing 12 months, Q3 FY2024 through Q2 FY2025, summed from the four most recent quarterly filings.

TITAN PHARMACEUTICAL INC (TTNP) reported -$0.65 in diluted earnings per share in Q2 2025. This represents an increase of 71.6% from the same quarter a year earlier.

Diluted earnings per share divides net income by the share count the company would have if every option and convertible security were exercised, which is the more conservative of the two per-share figures a filer reports. This page lists what TITAN PHARMACEUTICAL INC (TTNP) reported on that line in every period on record.